Mylan launching generic version of EpiPenNEW YORK — Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine.The company said today that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack. It will be available in both 0.15 mg and 0.30 mg strengths.Mylan said that it anticipates having the generic versions available in the next several weeks. It will continue to market and distribute branded EpiPen.The company charges $608 for a two-pack of the branded EpiPen. Mylan said it will keep in place the $300 savings card for the branded EpiPen and the revised patient assistance program announced last week.

Mazda recalls SUVs over potential steering problemNEW YORK — Mazda is recalling more than 190,000 CX-7 sport utility vehicles because of a potentially dangerous steering control defect.The recall involves vehicles made from Feb. 14, 2006 through May 9, 2012. Last year, the company recalled more than 190,000 CX-9 SUVs made between 2007 and 2014 because of concerns over steering control loss.In the latest recall, the National Highway Traffic Safety Administration said that water may enter the front suspension ball joint fittings. Water from salted roadways in the winter months can result in corrosion loosening ball joint fittings, which could eventually result in a loss of steering control.

GM recalling ’13 Equinox, Terrain due to wiper issueGeneral Motors is recalling nearly 368,000 vehicles to fix a defective part that could prevent the windshield wipers from working.The problem affects the 2013 models of the Chevrolet Equinox and GMC Terrain. GM says those vehicles were built with ball joints that could corrode and wear out to render the windshield wipers inoperable.A report filed with government regulators says a GM manager in Canada spotted the potential safety hazard last December. The auto manufacturer opened an investigation in March and decided to issue a recall earlier this month.